- Alcon Cares to donate 100 reprocessed Infiniti® units to clinics helping underserved patients in Asia, Central and South America, and Africa over the next three years
- Program to increase access to eye care and the number of phacoemulsification (phaco) cataract surgeries conducted by building local capacity and sustainability
- Goal is to perform 200,000 phaco surgeries and train at least 400 doctors by the end of December 2020
Alcon, the global leader in eye care and a division of Novartis, today announced Alcon Cares Project 100, which aims to reduce cataract blindness by providing equipment to perform phaco surgeries. Alcon Cares, a foundation that oversees equipment and product donations to those in need, will give 100 reprocessed Infiniti units to eligible clinics in Asia, Central and South America, and Africa over the next three years, making it one of the largest eye care equipment donations of its kind.
“Alcon Cares Project 100 aligns with our global efforts to combat cataract blindness and our mission to enhance sight and improve lives,” said David Endicott, Chairman of Alcon Cares and Chief Operating Officer, Alcon. “Cataracts are one of the leading causes of blindness and the World Health Organization recognizes cataract surgery as one of the most cost-effective treatments offered in developing countries. With 100 Infiniti units being placed in underserved markets, thousands of patients will receive the gift of sight. Additionally, hundreds of doctors who will be trained in phaco surgery in those clinics will be able to go on to provide quality care to thousands more.”
For more Information visit : https://www.novartis.com/news/media-releases/alcon-cares-project-100-commits-reducing-cataract-blindness-globally